Veracyte

Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
Xconomy
Veracyte
NanoString
diagnostics
Flag link:
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More
Xconomy
ASCO 2019
cancer
immunotherapy
diagnostics
Veracyte
Grail
Moderna Therapeutics
Amgen
Nektar Therapeutics
Blueprint Medicines
Merck
AstraZeneca
Roche
breast cancer
Flag link:
Veracyte Presents Data Demonstrating Afirma's Success in Reducing Unnecessary Surgery
Veracyte Presents Data Demonstrating Afirma's Success in Reducing Unnecessary Surgery
CP Wire
Veracyte
diagnostics
thyroid cancer
thyroid nodules
Flag link:
Veracyte Presents Data Demonstrating Afirma's Success in Reducing Unnecessary Surgery
Veracyte
thyroid cancer
Flag link:
Veracyte to Present Data Supporting Use of Their Non-Invasive Diagnostics for Lung Diseases
Veracyte to Present Data Supporting Use of Their Non-Invasive Diagnostics for Lung Diseases
CP Wire
Veracyte
lung cancer
devices
bronchoscopy
Percepta Bronchial Genomic Classifier
Flag link:
Veracyte to Present Data Supporting Use of Their Non-Invasive Diagnostics for Lung Diseases
Veracyte
lung cancer
devices
Flag link:
Veracyte misses 3Q net income and revenue expectations
Veracyte misses 3Q net income and revenue expectations
Yahoo/AP
Veracyte
earnings
Flag link:
Why Veracyte Inc. Shares Stormed Higher
Why Veracyte Inc. Shares Stormed Higher
Motley Fool
Veracyte
Afirma Thyroid FNA Analysis
Flag link:
Veracyte, Inc. Announces Closing of Initial Public Offering
Veracyte, Inc. Announces Closing of Initial Public Offering
Yahoo
Veracyte
IPOs
Flag link:
Genzyme, Veracyte announce global co-promotion agreement
Genzyme, Veracyte announce global co-promotion agreement
The Fly on the Wall
Genzyme
Veracyte
Afirma Thyroid FNA Analysis
Flag link:
Dx company Veracyte lands $28M series B
Dx company Veracyte lands $28M series B
Veracyte
Series B
financing
diagnostics
Flag link: